Company environment · Targeted small molecules · FDA CDER
A targeted cancer pill, filing by filing
Repeated filings: the original application and later expansions. Start at the top to see what the company does, then the jobs AI models were given here and how each scored.
1What does this company do?
A drug company with a targeted pill for rare cancers.
The pill was first approved for one rare tumor, then filed again for other related diseases — and each filing re-decides what the label may claim.
For experts
Sponsor of a targeted small molecule for rare tumors; every task is a freeze gate on a different application or supplement.
2Where is the product on its way to patients?
Each job is a filing about to be locked and sent to the FDA.
- 1Discovery
- 2Lab & animal studies
- 3Human trials
- 4Filing & review
- The product is here
- 5Approved
- 6On the market
Every filing has a “freeze”: after it, the documents go out as they are — so the clinical results, the label and the quality records must all agree before then.
For experts
NDA and supplemental applications under change-control freezes; clinical, labeling, quality, and publishing records each carry a version that could govern.
3What is happening right now?
A filing freezes today, and the working documents don’t agree.
The team must decide which study population, analysis and document version govern each claim.
4Which jobs were the models given?
5 jobs, each graded against a specialist’s checklist.
Scores are checks passed out of checks in the list. Each model ran each job once.
This company’s files stay private.
The jobs on this page are scored as part of the official 71-task benchmark. The files, the model’s steps, and each check stay unpublished, because they come from a real product’s records. To follow a job all the way down, open one of our open companion showcases (evaluated separately from the benchmark totals).
Havenor Therapeutics (fictional showcase) →
Broad Institute (public FDA record showcase) →